ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,648.14
0.30%
Dow Jones
40,858.85
1.61%
US Dollar vs MXN
17.6721
-0.33%
Brent Oil
83.445
-1.06%
Bitcoin
64,484.23
-0.57%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) Noticias

CGEN

Compugen (CGEN)

Compugen Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CGEN
FechaHoraFuenteTítuloSímboloCompañía
05/03/201415:05Business WireCompugen Ltd. Closes Public Offering of Ordinary SharesNASDAQ:CGENCompugen Ltd
28/02/201413:49Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CGENCompugen Ltd
28/02/201413:47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CGENCompugen Ltd
28/02/201408:15Business WireCompugen Ltd. Prices Public Offering of Ordinary SharesNASDAQ:CGENCompugen Ltd
27/02/201415:09Business WireCompugen Ltd. Announces Proposed Public Offering of Ordinary SharesNASDAQ:CGENCompugen Ltd
20/02/201406:00Business WireCompugen to Present Cancer Immunotherapy Programs at Three International Cancer Conferences in MarchNASDAQ:CGENCompugen Ltd
18/02/201416:04Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CGENCompugen Ltd
14/02/201407:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CGENCompugen Ltd
11/02/201406:00Business WireCompugen Ltd. Reports Fourth Quarter and Calendar 2013 ResultsNASDAQ:CGENCompugen Ltd
04/02/201406:00Business WireCompugen Fourth Quarter and Yearend 2013 Conference Call Scheduled for Tuesday, February 11, 2014 at 10:00 AM ESTNASDAQ:CGENCompugen Ltd
22/01/201406:00Business WireCompugen to Present Predictive Methodology for Discovery of Novel Immune Checkpoints at the Washington BioLeaders ForumNASDAQ:CGENCompugen Ltd
21/01/201406:00Business WireCompugen Announces Addition of Prof. Drew Pardoll to Its Scientific Advisory BoardNASDAQ:CGENCompugen Ltd
07/01/201408:26Business WireCompugen to Significantly Expand Immuno-Oncology Activities During 2014NASDAQ:CGENCompugen Ltd
11/12/201306:00Business WireCompugen Discloses Discovery of Five Potential Cancer Targets for Antibody Drug Conjugate TherapyNASDAQ:CGENCompugen Ltd
29/10/201308:25Business WireCompugen Ltd. Reports Third Quarter 2013 Financial ResultsNASDAQ:CGENCompugen Ltd
22/10/201306:00Business WireCompugen Third Quarter 2013 Conference Call Scheduled for Tuesday, October 29, 2013 at 10:00 AM ESTNASDAQ:CGENCompugen Ltd
16/10/201306:00Business WireCompugen Presents Experimental Results Supporting Induction of Immune Tolerance by CGEN-15001 Drug CandidateNASDAQ:CGENCompugen Ltd
09/10/201306:00Business WireCompugen Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal ModelNASDAQ:CGENCompugen Ltd
17/09/201307:22Business WireCompugen Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumor ProgressionNASDAQ:CGENCompugen Ltd
26/08/201306:00Business WireCompugen Establishes Scientific Advisory Board to Guide Pipeline Program DevelopmentNASDAQ:CGENCompugen Ltd
05/08/201308:20Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:CGENCompugen Ltd
05/08/201306:10Business WireCompugen Second Quarter 2013 Conference Call Scheduled for Wednesday, August 7, 2013 at 10:00 AM EDTNASDAQ:CGENCompugen Ltd
05/08/201306:03Dow Jones NewsCompugen, Bayer to Collaborate on Antibody-Based Cancer ImmunotherapiesNASDAQ:CGENCompugen Ltd
05/08/201305:10Business WireCompugen Announces Collaboration and License Agreement with Bayer for Antibody-Based Cancer ImmunotherapiesNASDAQ:CGENCompugen Ltd
17/07/201306:00Business WireCompugen Discloses Predictive Structural Biology Infrastructure Platform for Enhanced Discovery of Novel DrugsNASDAQ:CGENCompugen Ltd
15/07/201306:00Business WireCompugen Announces US Patent Allowance for Drug Candidate Recently Presented at 2013 American Thoracic Society MeetingNASDAQ:CGENCompugen Ltd
27/05/201306:00Business WireCompugen to Present at Jefferies 2013 Global Healthcare ConferenceNASDAQ:CGENCompugen Ltd
25/04/201306:00Business WireCompugen Ltd. Reports First Quarter 2013 Financial ResultsNASDAQ:CGENCompugen Ltd
23/04/201306:00Business WireCompugen to Present at the 12th Annual Needham Healthcare ConferenceNASDAQ:CGENCompugen Ltd
18/04/201309:47Business WireCompugen First Quarter 2013 Conference Call Scheduled for Thursday, April 25, 2013 at 10:00 AM EDTNASDAQ:CGENCompugen Ltd
 Showing the most relevant articles for your search:NASDAQ:CGEN

Su Consulta Reciente

COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MRK
Merck
CCOM
OILBRENT
Brent Oil
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
NYSE
BAC
Bank of America
NYSE
XOM
Exxon Mobil
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados